Global Peptide Therapeutics Market Report and Forecast 2024-2032

Global Peptide Therapeutics Market Outlook

The global peptide therapeutics market value was USD 36.1 billion in 2023, driven by the rising advancements in peptide synthesis technologies across the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to achieve a value of USD 69.9 billion by 2032.

The Oral Segment to Hold a Significant Share in the Global Peptide Therapeutics Industry

The oral segment based on the route of administration is expected to account for a significant share in the market. The growing efforts by the drug developers to facilitate oral delivery of peptides due to the increased inclination of people towards minimally invasive treatments are likely to boost the segment growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Additionally, orally delivered peptide therapeutics facilitate patient compliance, diversify the treatment options, offer ease of administration, and boost marketability. These factors are likely to aid the market growth. Moreover, the expansion of the major biotechnology companies specialising in the oral delivery of peptides is anticipated to bolster the market growth in the forecast period.

North America Accounts for a Significant Share in the Market

The peptide therapeutics industry in North America is driven by factors such as the strong pharmaceutical and biopharmaceutical ecosystem in the region, easy access to medical facilities, and rapid growth in the development of therapeutic proteins. A considerable increase in the number of protein-based drugs, coupled with the increased investments to develop new therapeutic proteins for a wide range of ailments has supported the regional market expansion. In addition, the favourable government policies encouraging the sales of peptide-based drugs are anticipated to further aid the market growth in the region.

Peptide Therapeutics: Market Segmentation

Peptide therapeutics can be defined as peptide-based therapeutics used to treat various diseases. Peptide therapeutics mimic the functions of the naturally occurring peptides in the human body, further serving as a promising basis for targeting a range of diseases. They are often well tolerated by the body and have the potential for decreased off-target side effects.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on marketing type, the market has been segmented into:

• Generic
• Branded

The segmentation of the market based on application is as follows:

• Gastrointestinal Disorders
• Neurological Disorders
• Metabolic Disorders
• Cancer
• Cardiovascular
• Others

On the basis of route of administration, the market is divided into:

• Parenteral
• Oral
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Rising Cases of Chronic Diseases, coupled with the Increasing Prevalence of Cancer to Boost the Growth of the Peptide Therapeutics Industry

The rising cases of chronic diseases and the increasing prevalence of cancer are driving the global peptide therapeutics industry. Additionally, there has been a significant surge in the incidences of metabolic diseases such as diabetes among the geriatric population. Unhealthy and poor lifestyles led by people with hectic and busy schedules are likely to increase the risk of various kinds of diseases, thereby enhancing the therapeutic use of peptide drugs for different treatments. Hence, these factors are likely to provide impetus to the peptide therapeutics industry.  The complexity associated with large peptides is likely to restrain the market growth, however, the growing availability of biosimilars is expected to aid the market in the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global Peptide Therapeutics Market

The report gives a detailed analysis of the following key players in the global peptide therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Pfizer Inc.
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Novartis AG
• Amgen Inc.
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

Peptide Therapeutics Market Report Snapshots

Peptide Therapeutics Market Size

Peptide Therapeutics Market Growth

Peptide Therapeutics Companies